u/clara_weiss

Nobody warned me about constipation and I would have liked the warning. It was not dangerous, it was just deeply unpleasant and completely unexpected.

What analytical method was used — this is not the usual peptide assay question?

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

Independent purity data on this compound is sparse compared with the older molecules, simply because far fewer members have paid for testing. Sparse data means wide uncertainty, not a verdict.

Right — the volume you add is the only variable you control here, and the cake does not change it meaningfully.

Which receptor family are you attributing that effect to?

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

the log is cumulative, that is the whole value of it

It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon arm is the genuinely novel component and it is the one with the least human outcome data behind it.

Amylin is co-secreted with insulin and acts on satiety and gastric emptying through its own receptor complexes. An amylin analogue is therefore not a variant of an incretin agonist — it is a different signalling axis.

Disagree with the "more water is safer" framing. It is not safer, it is just a different number to divide by.

The fatigue turned out to be that I was eating about a third of what I thought I was. Tracked it for a week and the mystery evaporated.

PBS-subsidised or private script?

private script pricing varies by pharmacy here too

Adding more water does not change how much peptide is in the vial.

Adding one thing — put the date on the label too. Concentration plus date and you can never mix two vials up.

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

the co-agonism argument is about complementary mechanisms

Bacteriostatic water contains benzyl alcohol as a preservative, which is what makes repeated entry into the same vial reasonable. Plain sterile water has no preservative.

How long after a step up did this start?

Resistance training, and at what frequency?

The fatigue profile felt different rather than worse. Hard to describe and impossible to quantify, so take it as an impression.

identity testing on a small molecule is a different analytical problem

Spent 14 weeks confused about this until somebody drew the table for me. 10mg, 2mL, 5mg/mL, 2.5mg is 50 units. That is the whole thing.

split a vial across two services once and you will never argue about ground truth again

The effect on gastric emptying is most pronounced early and attenuates with continued dosing, which is the mechanism behind the "it settles at a stable dose" pattern the whole board reports.

Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.

A symptom that begins the day after the shot and fades by day four tracks the exposure curve. One that appears at random in week 51 probably does not, and that is worth saying to a clinician rather than to us.

a lot of the confident posting here is extrapolation

This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.

split a vial across two services once and you will never argue about ground truth again

That service reports area percent by default. Worth stating, since the thread has been comparing it to a mass figure.

That figure is a private price at one pharmacy, not a national one.

Disagreeing with this bit: that advice predates the change in compounded arrangements.

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

Which programme and which readout are you quoting?

Nothing containing this compound is approved by any regulator, and research-use-only material is not approved for human use.

The injection-site soreness profile felt different rather than worse. Hard to describe and impossible to quantify, so take it as an impression.

split a vial across two services once and you will never argue about ground truth again

Yes. Two services on the same batch is the strongest thing an individual member can produce, and it is not expensive.